Lissandra Dal Lago
- Oncology top 2%
- HER2/EGFR in Cancer Research 13
- Cancer Treatment and Pharmacology 9
- Peptidase Inhibition and Analysis 4
- Neutropenia and Cancer Infections 4
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults 11
- Dermatology top 5%
- Cancer Research top 10%
- Breast Cancer Treatment Studies 11
- Clinical Biochemistry top 5%
-
- Chronic Lymphocytic Leukemia Research 4
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- David CameronDamien C. WeberGary H. LymanNora KearneyMatti AaproJulia BohliusC. ZielinskiRuth Pettengell
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (6 papers)PLoS ONE (1 paper)
In The Last Decade
Lissandra Dal Lago
48 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.2k
- Geriatrics and Gerontology 132
- Dermatology 166
- Cancer Research 219
- Clinical Biochemistry 95
Countries citing papers authored by Lissandra Dal Lago
This map shows the geographic impact of Lissandra Dal Lago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lissandra Dal Lago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lissandra Dal Lago more than expected).
Fields of papers citing papers by Lissandra Dal Lago
This network shows the impact of papers produced by Lissandra Dal Lago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lissandra Dal Lago. The network helps show where Lissandra Dal Lago may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lissandra Dal Lago, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 6 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 14 | |
| 7 | 2019 | 11 | |
| 8 | 2018 | 81 | |
| 9 | 2016 | 39 | |
| 10 | 2016 | 4 | |
| 11 | O comitê de ética em pesquisa na Universidade Federal de Santa Maria: um breve histórico | 2011 | 0 |
| 12 | Desnutrição em pacientes com câncer avançado: uma revisão com abordagem para o clínico | 2011 | 1 |
| 13 | Diagnóstico e tratamento da DPOC exacerbada na emergência | 2010 | 2 |
| 14 | 2008 | 18 | |
| 15 | 2007 | 33 | |
| 16 | 2006 | 59 | |
| 17 | 2006 | 13 | |
| 18 | 2006 | 37 | |
| 19 | 2003 | 18 | |
| 20 | 2002 | 67 |
About Lissandra Dal Lago
Lissandra Dal Lago is a scholar working on Geriatrics and Gerontology, Oncology and Cancer Research, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Frailty in Older Adults (11 papers), Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (9 papers), Chronic Lymphocytic Leukemia Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Advanced Breast Cancer Therapies (4 papers) and Neutropenia and Cancer Infections (4 papers). The work is most often cited by research in Oncology (1.2k citations), Geriatrics and Gerontology (132 citations) and Dermatology (166 citations). Lissandra Dal Lago has collaborated with scholars based in Belgium, Brazil and Italy. Frequent co-authors include David Cameron, Damien C. Weber, Gary H. Lyman, Nora Kearney, Matti Aapro, Julia Bohlius, C. Zielinski, Ruth Pettengell, Jan Walewski and Vivianne C. G. Tjan‐Heijnen. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.